Lista de obras - Markus Möbs - Dominio Público Uruguay

Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study

artículo científico publicado en 2013

Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome

artículo científico publicado en 2014

Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling.

artículo científico publicado en 2012

Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target.

artículo científico publicado en 2015

DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer.

artículo científico publicado en 2017

Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.

artículo científico publicado en 2016

Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model

artículo científico publicado en 2018

Evaluation of T-cell clonality in archival skin biopsy samples of cutaneous T-cell lymphomas using the biomed-2 PCR protocol.

artículo científico

Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T-cell lymphoma

artículo científico publicado en 2015

Genome-Wide Analysis of Interchromosomal Interaction Probabilities Reveals Chained Translocations and Overrepresentation of Translocation Breakpoints in Genes in a Cutaneous T-Cell Lymphoma Cell Line.

artículo científico publicado en 2018

Genomic loss of the putative tumor suppressor gene E2A in human lymphoma.

artículo científico publicado en 2011

IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression

artículo científico publicado en 2016

IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.

artículo científico publicado en 2014

Identification of multiple complex rearrangements associated with deletions in the 6q23-27 region in Sézary syndrome.

artículo científico publicado en 2013

Inactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma.

artículo científico publicado en 2016

Mechanisms of targeting the MDM2-p53-FOXM1 axis in well-differentiated intestinal neuroendocrine tumors

artículo científico publicado en 2017

Molecular diagnostics in cutaneous lymphomas.

artículo científico publicado en 2013

Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial

artículo científico publicado en 2019

Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS

scientific article published on 13 June 2019

Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand

artículo científico publicado en 2011

Pathogenesis of Mycosis fungoides ⬇️

artículo científico publicado el 3 de marzo de 2011

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.

artículo científico publicado en 2017

T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity

artículo científico publicado en 2005

T-cell receptor gene rearrangement analysis of sequential biopsies in cutaneous T-cell lymphomas with the Biomed-2 PCR reveals transient T-cell clones in addition to the tumor clone.

artículo científico publicado en 2014

The Effects of Arsenic Trioxide in Combination with Retinoic Acids on Cutaneous T-Cell Lymphoma Cell Lines.

artículo científico publicado en 2016

The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.

artículo científico publicado en 2017

The tumour suppressor p53 is frequently nonfunctional in Sézary syndrome.

artículo científico publicado en 2012

Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.

artículo científico publicado en 2011

Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome

artículo científico publicado en 2008

[Cutaneous malignant lymphomas. Update on diagnosis and therapy of cutaneous T-cell lymphomas].

artículo científico publicado en 2012

Lista de obras de Markus Möbs

Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study

Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome

Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling.

Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target.

DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer.

Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.

Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model

Evaluation of T-cell clonality in archival skin biopsy samples of cutaneous T-cell lymphomas using the biomed-2 PCR protocol.

Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T-cell lymphoma

Genome-Wide Analysis of Interchromosomal Interaction Probabilities Reveals Chained Translocations and Overrepresentation of Translocation Breakpoints in Genes in a Cutaneous T-Cell Lymphoma Cell Line.

Genomic loss of the putative tumor suppressor gene E2A in human lymphoma.

IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression

IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.

Identification of multiple complex rearrangements associated with deletions in the 6q23-27 region in Sézary syndrome.

Inactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma.

Mechanisms of targeting the MDM2-p53-FOXM1 axis in well-differentiated intestinal neuroendocrine tumors

Molecular diagnostics in cutaneous lymphomas.

Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial

Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS

Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand

Pathogenesis of Mycosis fungoides ⬇️

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.

T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity

T-cell receptor gene rearrangement analysis of sequential biopsies in cutaneous T-cell lymphomas with the Biomed-2 PCR reveals transient T-cell clones in addition to the tumor clone.

The Effects of Arsenic Trioxide in Combination with Retinoic Acids on Cutaneous T-Cell Lymphoma Cell Lines.

The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.

The tumour suppressor p53 is frequently nonfunctional in Sézary syndrome.

Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.

Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome

[Cutaneous malignant lymphomas. Update on diagnosis and therapy of cutaneous T-cell lymphomas].